Pretreatment prognostic factors associated with outcomes for first-line FCR-based treatments in previously untreated CLL.

6517 Background: First-line chemoimmunotherapy with fludarabine, cyclophosphamide, and rituximab (FCR) demonstrated improved outcomes, including survival, for fit patients (pts) with CLL. Modificat...